# Headache Pharmacology

> Headache Pharmacology (iPhone/iPad app by ATIF ELNIL.)

- Source: https://appshunter.io/ios/app/headache-pharmacology/id6761260499 (this page in markdown: same URL + `.md`)
- Developer: [ATIF ELNIL](https://appshunter.io/developer/1886307011)
- Category: Medical
- Price: Free with in-app purchases (on sale, was $12.99)
- Age rating: 17+
- Requires: iOS 16.0 · 1 MB
- Languages: English
- Released: 2026-03-27
- Data updated: 2026-07-02
- User reviews in markdown: https://appshunter.io/ios/app/headache-pharmacology/id6761260499/reviews.md

## What is Headache Pharmacology?

Headache Pharmacology is a comprehensive clinical reference app for neurologists, headache specialists, and healthcare professionals managing headache disorders.
Drug Coverage:
Triptans (7 drugs), Gepants (Rimegepant, Atogepant), Ditans (Lasmiditan), Ergot alkaloids, CGRP monoclonal antibodies (Erenumab, Fremanezumab, Galcanezumab, Eptinezumab), and all major preventive agents.
Clinical Protocols:
Step-by-step acute migraine management, NICE NG150 prevention pathway, cluster headache acute and preventive therapy, and special situations including pregnancy, cardiovascular disease, and medication overuse headache.
References:
All NICE guidelines, EHF 2022 consensus, landmark trials and MHRA safety guidance have fully tappable links.
For qualified healthcare professionals only. Always verify doses against the current BNF before prescribing.
Developed by Dr Atif Elnil MBBS MRCP, Neurology Department, St George's Hospital, London, UK.

## Pricing and in-app purchases

Base price: Free.

**One-time purchases**

| Purchase | Price | Type |
| --- | --- | --- |
| Full Access | $6.99 | one-time |



## Version history (last 3 releases)

### 1.0.2 — 2026-05-26

Added full in-app purchase unlock. Complete access to all drug profiles, treatment protocols, and specialist pathways.

### 1.0.1 — 2026-05-05

This update brings a complete redesign of the app with a new mobile-optimised interface and significantly expanded clinical content.
New Features:
Fully redesigned interface with intuitive bottom navigation (Home, Drugs, Acute, Prevent, Special, References)
Complete drug profiles for all 22+ headache medications including full mechanism, dosing, side effects, interactions, contraindications and monitoring
New Gepants section Rimegepant (Vydura) and Atogepant (Aquipta) with dual acute/preventive indications
New Ditans section Lasmiditan (Rayvow) with mandatory MHRA driving restriction guidance
All 4 NICE-approved CGRP monoclonal antibodies (Erenumab, Fremanezumab, Galcanezumab, Eptinezumab)
Triptan comparison table with onset, half-life and best use
Step-by-step acute migraine protocol and prevention protocol per NICE NG150
Cluster headache acute and preventive management
Special situations pregnancy, breastfeeding, cardiovascular disease, medication overuse headache, migraine with aura
References & Citations all NICE guidelines, EHF consensus, landmark trials (STRIVE, HALO EM, ACHIEVE I, ADVANCE) and MHRA safety guidance as tappable links

Support URL and App Privacy link was also updated.

Content updated to: NICE NG150 (2021), EHF 2022, BASH Guidelines, BNF
Developed by Dr Atif Elnil MBBS MRCP, Neurology Department, St George's Hospital, London, UK

### 1.0 — 2026-03-27

No release notes.

## More apps by ATIF ELNIL

- [Antiseizure Medications](https://appshunter.io/ios/app/antiseizure-medications/id6760823031)
- [NIHSS Calculator](https://appshunter.io/ios/app/nihss-calculator/id6760891744)
- [HyperRef Clinical](https://appshunter.io/ios/app/hyperref-clinical/id6760921930)
- [PD Drug Reference](https://appshunter.io/ios/app/pd-drug-reference/id6760972673)
- [MS DMT Reference](https://appshunter.io/ios/app/ms-dmt-reference/id6761038062)
- [ElectroBalance Pro](https://appshunter.io/ios/app/electrobalance-pro/id6761238034)

All apps by ATIF ELNIL: https://appshunter.io/developer/1886307011

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-07-02.*